Evidence map›Paper›PMID 27621197›Full record

ArticlePsychoneuroendocrinology2016

Effects of chronic oxytocin on attention to dynamic facial expressions in infant macaques.

Lisa A Parr, Jenna M Brooks, Trina Jonesteller, Shannon Moss, James O Jordano, Thomas R Heitz

Open access · greenAbstract read
In one paragraph

Article in Psychoneuroendocrinology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
6.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Social touch alters newborn monkey behavior.Infant behavior & development · 2019
    Article
  6. Hippocampal deficits in neurodevelopmental disorders.Neurobiology of learning and memory · 2019
    Review
  7. Differences in how macaques monitor others: Does serotonin play a central role?Wiley interdisciplinary reviews. Cognitive science · 2019
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Lisa A ParrYerkes National Primate Research Center, 954 Gatewood Rd., Atlanta, GA, 30329, USA; Department of Psychiatry and Behavioral Science, Emory University, Atlanta, GA, 30322, USA; Center for Translational Social Neuroscience, Emory University, Atlanta, GA, 30329, USA. Electronic address: lparr@emory.edu.
Jenna M BrooksYerkes National Primate Research Center, 954 Gatewood Rd., Atlanta, GA, 30329, USA.
Trina JonestellerYerkes National Primate Research Center, 954 Gatewood Rd., Atlanta, GA, 30329, USA.
Shannon MossYerkes National Primate Research Center, 954 Gatewood Rd., Atlanta, GA, 30329, USA.
James O JordanoDepartment of Biology, Emory University, Atlanta, GA, 30322, USA.
Thomas R HeitzYerkes National Primate Research Center, 954 Gatewood Rd., Atlanta, GA, 30329, USA.
Emory National Primate Research CenterEmory University · US

Funding

Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
YNPRC NHP CLINICAL MEDICINE RESIDENCY PROGRAM - SUPPLEMENTP51RR000165 · NCRR · EMORY UNIVERSITY · PI RENGARAJAN, JYOTHI · 1985 to 2011
$114.0M
Effect of Oxytocin on Brain, Behavior, and Social DevelopmentR01MH104534 · NIMH · EMORY UNIVERSITY · PI PARR, LISA A. · 2015 to 2019
$3.3M
NCRR NIH HHS P51 RR000165NIH HHS P51 OD011132NIMH NIH HHS R01 MH104534
6 · The paper itself

Abstract

Studies in a variety of species have reported enhanced prosocial effects after an acute administration of the neuromodulating hormone, oxytocin (OT). Although the exact mechanisms underlying these effects are not fully understood, there is broad interest in developing OT into a treatment for social deficits. Only a few studies, however, have examined the effects of OT if given repeatedly during early development, the period when early intervention is likely to have the greatest benefits for reversing the progression towards social impairment. Those studies, exclusively in rodents, report mixed results. Some have shown enhancement of prosocial behavior, including increased social exploration, but others have shown anti-social effects, including increased aggression. In the present study, infant rhesus macaques were treated with a high-frequency (3× per week) or low-frequency (1× per week) dose of intranasal oxytocin (IN-OT) or placebo (IN-saline) between two and six months of age, after which their reactions to dynamic facial expressions (neutral, lipsmacking and threats) were measured. Results showed that IN-OT, compared to placebo, increased the time monkeys spent viewing the expression videos, but selectively reduced attention to the eyes in neutral faces in a dose dependent manner. The mechanism for this non-prosocial effect may be that repeated IN-OT administration down-regulates the expression of OT receptors in brain regions important for regulating social attention. Consequently, our results raise questions about the efficacy of implementing chronic IN-OT as a pharmacotherapy for the treatment of social deficits, particularly if given early in development. More work is needed, not only to identify optimal treatment schedules, but also to understand how IN-OT exerts its influences on the brain and behavior.

Indexed as

EyeFacial ExpressionSocial PerceptionAnimalsAttentionEye Movement MeasurementsFacial RecognitionMacaca mulattaMaleOxytocinOxytocinDevelopmentEye-trackingFacial expressionGazeInfant macaqueOxytocin

Identifiers

PMID27621197
PMCPMC5159270
OpenAlexW2518331754

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.